Among the targets, BDNF, BCL2, BAX, ATF2, APP, TNF, APOE, TGFB1, AKT1, SOD1, AChE, ACE, PPARG (PPAR-γ), PIK3CA, ABCA1, NFKB1, NFE2L2 (Nrf2), MMP9, MAPK1, IL6, IL1B, HMOX1, GRIN2A (GluN2A), CAT, CASP3, and CASP9, each was connected with NDD, indicating the involvement of these targets or others to their upstream signaling as a potential drug-target for fucosterol in the NDD treatment. The gene discussed is CASP9; the disease is Neurodevelopmental delay.